Therapy for metastatic pancreatic neuroendocrine tumors.
about
Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio.Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors.microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.
P2860
Therapy for metastatic pancreatic neuroendocrine tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Therapy for metastatic pancreatic neuroendocrine tumors.
@ast
Therapy for metastatic pancreatic neuroendocrine tumors.
@en
Therapy for metastatic pancreatic neuroendocrine tumors.
@nl
type
label
Therapy for metastatic pancreatic neuroendocrine tumors.
@ast
Therapy for metastatic pancreatic neuroendocrine tumors.
@en
Therapy for metastatic pancreatic neuroendocrine tumors.
@nl
prefLabel
Therapy for metastatic pancreatic neuroendocrine tumors.
@ast
Therapy for metastatic pancreatic neuroendocrine tumors.
@en
Therapy for metastatic pancreatic neuroendocrine tumors.
@nl
P2093
P2860
P1476
Therapy for metastatic pancreatic neuroendocrine tumors.
@en
P2093
Dario Conte
Maddalena Peracchi
Roberta Elisa Rossi
Sara Massironi
P2860
P356
10.3978/J.ISSN.2305-5839.2013.03.01
P577
2014-01-01T00:00:00Z